Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

A systematic review and meta-analysis of 15 studies found that ketogenic diets were associated with short-term reductions in ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.